Skip to content

We Have Lift Off: Codiak BioSciences Bears Down with Exosomes as a Therapeutic Modality

GEN Edge speaks with Codiak Biosciences’ president and CEO Douglas E. Williams, PhD, about how the company has grown from the ground up to develop a new class of medicines with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need. Codiak designs and engineers exosomes, loads them with various types of therapeutic molecules including nucleic acids and small molecules, and directs them to target and specific cells . . .

No comment yet, add your voice below!


Add a Comment

Your email address will not be published. Required fields are marked *